UK Markets close in 3 hrs 17 mins

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.25+0.04 (+0.77%)
At close: 04:00PM EDT
Full screen
Loading interactive chart…
  • Business Wire

    LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

    ORLANDO, Fla., September 08, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced the application for certification of the ALLY™ Adaptive Cataract Treatment System ("ALLY" or the "ALLY System") in the European Union.

  • Business Wire

    First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System

    ORLANDO, Fla., August 16, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced the first commercial cases performed with the ALLY™ Adaptive Cataract Treatment System ("ALLY" or the "ALLY System") by Robert Weinstock, MD at The Eye Institute of West Florida. Dr. Weinstock performed 15 laser-assisted cataract surgery cases following the recent insta

  • Business Wire

    LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update

    ORLANDO, Fla., August 08, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2022 and provided an update on operational initiatives.